ReST Therapeutics establishes U.S. headquarters in New Haven

Paris-based ReST Therapeutics chose New Haven, Connecticut for its U.S. headquarters, planning to invest $7.5 million and create 6 new jobs.

“Paris, France-based ReST Therapeutics recently announced its entry into the U.S. market by choosing New Haven as the location for its U.S. headquarters.”bdavison.bloxcms.com

• 1 source
• bdavison.bloxcms.comFour Life Sciences Companies Announce Expansions in Connecticut | | bdavison.bloxcms.comAdvanceCT, MannKind Corporation, Millstone Medical, ReST Therapeutics, Revalia BioDec 19, 2023

Summarized from public sources; check the original articles before acting on it.